Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.640 | 2.640 | 0.000 |
Stocks | 97.360 | 97.360 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.569 | 21.770 |
Price to Book | 3.885 | 3.989 |
Price to Sales | 1.783 | 2.260 |
Price to Cash Flow | 20.591 | 16.880 |
Dividend Yield | 1.204 | 1.345 |
5 Years Earnings Growth | 13.529 | 11.341 |
Number of long holdings: 51
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Intuitive Surgical Inc | - | 4.28 | - | - | |
Boston Scientific Corp | - | 4.13 | - | - | |
Eli Lilly and Co | - | 4.11 | - | - | |
Merck & Co Inc | - | 4.09 | - | - | |
Cencora Inc | - | 3.87 | - | - | |
UCB | BE0003739530 | 3.52 | 128.65 | +1.70% | |
Vertex Pharmaceuticals Inc | - | 3.52 | - | - | |
Molina Healthcare Inc | - | 3.43 | - | - | |
Lonza Group | CH0013841017 | 3.33 | 486.40 | -0.45% | |
Biomarin Pharmaceutical Inc | - | 3.18 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Swisscanto CH IPF I Index Equity Fu | 6.6B | 10.60 | 8.37 | 9.76 | ||
Swisscanto CH IPF III Index EquAST | 3.81B | 10.63 | 7.97 | 9.33 | ||
Swisscanto CH IPF I Index Equity CH | 2.32B | 14.70 | 6.38 | 9.88 | ||
CH0315621927 | 1.86B | 9.13 | -6.73 | - | ||
CH0011792451 | 859.29M | -19.58 | 1.16 | 7.27 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review